New Drugs
نویسندگان
چکیده
منابع مشابه
NEW DRUGS DRUG NEWS NEW DRUGS H1N1 Influenza Virus Vaccines
NEW DRUGS H1N1 Influenza Virus Vaccines The FDA has approved four vaccines to protect the population against the 2009 pandemic H1N1 influenza virus. About 45 million doses should be available at 90,000 sites in October. The government has ordered 195 million doses. CSL Ltd., MedImmune LLC, Sanofi-Pasteur, and Novartis Vaccines/Diagnostics Ltd. are using the same processes to make the H1N1 vacci...
متن کاملNEW DRUGS NEW DRUGS Ferriprox Reduces Excess Iron
NEW DRUGS Ferriprox Reduces Excess Iron Deferiprone (Ferriprox, Apo-Pharma, Inc.) has been approved to treat iron overload resulting from blood transfusions in patients with thalassemia who have responded inadequately to previous chelation therapy. Thalassemia is a genetic blood disorder that causes anemia. Patients with thalassemia have excess iron levels from frequent blood transfusions, a se...
متن کاملNEW DRUGS NEW DRUGS Fusion Inhibitor for HIV
NEW DRUGS Fusion Inhibitor for HIV The Food and Drug Administration (FDA) has announced the accelerated approval of enfuvir tide (FuzeonTM, Roche) for use with other anti-HIV medications in adults and children ages six years and older with advanced human immunodeficiency virus (HIV) infection. Enfuvirtide is the first in a new class of medications called fusion inhibitors, which interfere with ...
متن کاملNEW DRUGS NEW DRUGS Efalizumab for Plaque Psoriasis
NEW DRUGS Efalizumab for Plaque Psoriasis Genentech, Inc., and Xoma, Ltd., have announced the approval of efalizumab (RaptivaTM) by the U.S. Food and Drug Administration (FDA) for the treatment of chronic, moderate-to-severe plaque psoriasis in adults age 18 or older who are candidates for systemic therapy or phototherapy. This is the first biological agent that is designed to provide continuou...
متن کاملNEW DRUGS DRUG NEWS NEW DRUGS Cervical Cancer Vaccine
NEW DRUGS Cervical Cancer Vaccine The Food and Drug Administration (FDA) has approved Gardasil (Merck), the first vaccine developed to prevent cervical cancer, precancerous genital lesions, and genital warts caused by human papilloma virus (HPV) types 6, 11, 16, and 18 for females nine to 26 years of age. This agent was evaluated and approved in six months under the FDA’s priority review proces...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pharmacy Today
سال: 2021
ISSN: ['1042-0991', '2773-0735']
DOI: https://doi.org/10.1016/j.ptdy.2021.06.004